SNAP-8 Research: What 2 Studies Show (2026) | RetatrutideCompare

SNAP-8 — 2 studies indexed on PubMed. Stronger SNAP-25 mimic than Argireline; competes with SNARE complex assembly. Half-life: Topical. FDA status: Cosmetic ingredient.

PubMed search-result count last fetched 2026-06-18. Records may include reviews, laboratory work, and animal studies; this is not a clinical trial count or a measure of efficacy.

Inspect the PubMed query and results

How many studies have been published on SNAP-8?

There are approximately 2 studies indexed on PubMed that mention SNAP-8 (Acetyl Octapeptide-3), based on a search last updated 2026-06-18.

Is SNAP-8 FDA-approved?

FDA status: Cosmetic ingredient.

How does SNAP-8 work?

Stronger SNAP-25 mimic than Argireline; competes with SNARE complex assembly.

Reference facts

Also known as: Acetyl Octapeptide-3
Category: Cosmetic & Skin
Mechanism of action: Stronger SNAP-25 mimic than Argireline; competes with SNARE complex assembly.
Targets: SNARE complex (in vitro)
Indications under research or approved: Cosmetic anti-wrinkle
Regulatory status (reference entry): Cosmetic ingredient
Half-life: Topical
Sequence: EEMQRRADL
Sequence notes: Acetyl octapeptide elongation of Argireline. C-terminal amide.
Molecular weight (Da): 1075
Originator / sponsor: Lipotec / Lubrizol
First reported: 2007

Primary References

Wang et al., J Cosmet Sci 2013 (SNAP-8)

Explore research articles about SNAP-8

This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.